While we found an encouraging trend toward the survival benefit favoring the DPP4i cohort, the statistical significance was not reached, likely secondary to small sample size.
← all excerpts
Impact of DPP4 Inhibitors in Survival of Patients With Prostate, Pancreas, and Breast Cancer.
1
—
—